Gainey Capital (GNC) Stock Price, News & Analysis

Company Overview

Gainey Capital Corp., a gold and silver exploration company, engages in the acquisition and exploration of mineral properties. The company owns the El Colomo project covering an area of 18,766 hectares; and a mill in the gold/silver-rich Sierra Madre Occidental trend in western Mexico. It also has an option to own a 100% interest in the Las Margaritas property, which consists of two mineral concessions encompassing a total of 500 hectares located in the State of Durango, Mexico. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: C$0.09 to C$0.09
• 50-Day Range: C$0.09 to C$0.09
• 52-Week Range: C$0.02 to C$0.11
• Volume: 147,882 shs
• Average Volume: 399,270 shs
• Market Capitalization: C$8.09 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GNC Stock Analysis - Frequently Asked Questions

How have GNC shares performed this year?

Gainey Capital's stock was trading at C$0.09 on January 1st, 2024. Since then, GNC stock has increased by 0.0% and is now trading at C$0.09.
View the best growth stocks for 2024 here.

How do I buy shares of Gainey Capital?

Shares of GNC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Gainey Capital own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Gainey Capital investors own include Adamis Pharmaceuticals (ADMP), Apartment Investment and Management (AIV), Geron (GERN), ObsEva (OBSV), Spectrum Pharmaceuticals (SPPI), Achieve Life Sciences (ACHV) and Akebia Therapeutics (AKBA).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Basic Materials
• Industry: Industrial Metals & Minerals
• Sub-Industry: N/A
• Current Symbol: CVE:GNC
• CUSIP: N/A
• CIK: N/A
• Web: www.gaineycapital.com
• Phone: +1-604-6873992
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.40
• Quick Ratio: 0.18

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 25.00
• Book Value: C$0.03 per share
• Price / Book: 2.83

Miscellaneous

• Outstanding Shares: 95,196,000
• Free Float: N/A
• Market Cap: C$8.09 million
• Optionable: Not Optionable
• Beta: N/A